Defective Drugs
A defective drug is any prescription or over-the-counter medication with serious or deadly side effects. Often times, a defective drug will make it into the market because the possible dangers were not identified or anticipated during clinical testing trials.
Each year in America, millions of people take prescription and over-the-counter medications to treat a variety of conditions, from minor colds to severe illnesses.
How a Defective Drug is Introduced into the Market
Pharmaceutical companies are driven by profits. This means that sometimes, in an attempt to increase sales, the safety risks associated with a certain drug will be overlooked. While it is the responsibility of the Food and Drug Administration (FDA) to determine whether a drug is safe for public use, the administration can also be at fault. If the FDA does not perform adequate research, or fails to administer the appropriate tests, a defective drug can be approved and introduced into the public sector.
The Drug Manufacturer’s Responsibility
A drug manufacturer must mandate all the necessary testing before seeking FDA approval for a particular drug. The manufacturer must also include any warnings about the side effects associated with that drug, along with possible complications of misuse. If an over-the-counter medication or prescription drug causes you serious injury, you can file a product liability claim to recover damages for your injuries.
Drug Recalls
A drug is deemed “defective” if the side effects associated with that drug outweigh its intended benefits. When this occurs, the FDA will issue a drug recall. Aside from drug recalls, the FDA will monitor drugs that are currently on the market and make changes to the labels, such as adding side effects and updating warnings as necessary. Consumer group petitions are also considered by the FDA.
Medications and Dangerous Side Effects
Side effects are the most common indicator that a drug may be defective. Several common side effects include:
- Liver damage
- Pulmonary dysfunction
- Increased risk of stroke or heart attack
- Kidney damage
- Heart damage
- Death
Drugs to Watch Out For
Some of the more dangerous drugs include:
- Meridia: a prescription drug used to treat obesity related to high cholesterol and high blood pressure, Meridia can also cause stroke, rapid heart rate and seizures.
- Hydroxycut: this weight loss pill was recalled because its range of side effects, from insomnia to increased blood pressure to liver failure.
- Crestor: this cholesterol-lowering drug has been linked to kidney failure and rhabdomyolysis, a serious life-threatening muscle condition.
- Zicam cold remedies: these products were recalled because of their link to anosmia, the loss of sense of smell.
- Yaz/Yasmin: this birth control pill contains dropsirenone, which has been linked to serious medical conditions including blood clots, stroke, heart attack, gall bladder injury and deep vein thrombosis.
- Provigil: this medication is prescribed to promote wakefulness for those who suffer from sleep apnea and narcolepsy. The drug is under investigation for causing Stevens-Johnson Syndrome, a life-threatening condition that causes cell death in your skin.
- Accutane: this medication to treat acne can lead to birth defects, psychological side effects and suicide.
- Serevent: this asthma medication can increase your risk of an asthma-related emergency.
Article Source : The Cochran Firm – Defective Drugs : ArticleBase
Erich Shrefler
If you or someone you love has been hurt by a defective drug, please visit the website for The Cochran Firm, serving clients nationwide.
Posted on February 13th, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
What To Do If I Have Suffered An Injury Due To A Recalled Product
From tomatoes and pet food to children’s toys and automobile parts, consumer products are constantly being recalled after they have been manufactured and sold to millions.
Sometimes a product is recalled before it can injure the masses. Other times, a product recall is too late and many consumers suffer injuries before learning that a product is dangerous.
Fortunately, if you are injured by a defective medical device or dangerous pharmaceutical, you can file a product recall claim to collect compensation for your injuries. A product liability suit also holds negligent manufacturers responsible for creating, distributing and selling a faulty product that puts consumer lives in danger.
How Defects Arise
Most injuries from defective products are a result of manufacturer negligence. A greedy company may be so eager to get their product approved by the Food and Drug Administration (FDA) that they cut corners by filing unfinished reports, skipping essential steps and writing incomplete product warnings.
A product recall can also arise from budget cuts. If funding for research and development has been cut, this may limit the tests necessary for determining whether a product is safe and effective. Design defects can also occur during the drug’s planning process, which may not be uncovered until the drug has been widely distributed.
Product Recall Compensation
If you or a loved one is injured by a defective product, you may be able to claim compensation for:
- The cost of treatment, including past and future medical care
- Lost wages and the inability to earn future income
- Emotional distress
- Pain and suffering
- Punitive damages to deter future negligent behavior
Consumer Responsibility
Fighting back against unsafe products is a consumer’s responsibility. If you are hurt by a defective device or drug, you have the power to help prevent the same injuries from happening to someone else.
No matter how small it seems, every product liability lawsuit takes power away from a profit-driven manufacturing company who believes creating defective products is acceptable. Conversely, each victim who remains silent is forfeiting the chance to stand up for their rights and to gain valuable compensation for injuries suffered.
Winning Your Case
If you have been hurt by a recalled product, you may be able to collect money from the manufacturer or retailer if you are able to prove there was indeed a defect. Maybe the appropriate safety warnings were not included or there was a flaw in the product’s design. Keep in mind that product liability cases are complex and often involve expert testimony.
The Importance of Legal Representation
Manufacturing companies also retain their own legal advisors, so you should speak to an experienced product liability attorney regarding your product recall suit. Most states require you to file a claim within two years of your product-related injury. If you are one of many victims injured by a product, you may file a class-action suit against the manufacturer. In this case, one attorney can represent an entire group of plaintiffs, and the damages are divided among the group.
If your injury occurred in the workplace, your claim may need to be coordinated with a worker’s compensation suit. Regardless of your situation, if you were injured by a product, you should speak to a lawyer as soon as possible.
Article Source : The Cochran Firm – What To Do If I Have Suffered An Injury Due To A Recalled Product : ArticleBase
Erich Shrefler
If you are the victim of a product recall, please visit the website for The Cochran Firm, serving clients nationwide.
Posted on February 13th, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Product Recalls And Defective Devices
A medical device includes any instrument, machine or implant that is used to enhance your overall health. A defective device is one that fails to work properly, resulting in patient injury and even death.
Defective medical devices are generally products such as pacemakers and defibrillators that fail because of improper design or harm a patient because of manufacturer negligence. However, devices such as x-ray machines and diagnostic equipment can also be defective and result in patient injuries.
Why They Are Defective
A majority of injuries caused by defective medical devices are the result of manufacturer negligence. Sometimes, companies are so eager to obtain approval by the Food and Drug Administration (FDA) to begin earning profits that they do not perform the necessary research or appropriate pre-clinical tests.
A medical device recall does not always require discontinued use or the removal of that device. It may mean that the device must be adjusted or checked. If it is discovered that your implanted device may fail, you should discuss with your doctor the risks of having it removed versus the risk of potential failure.
A product recall can also be the result of budget reductions. If funding for research and development has been cut, this may prevent necessary testing. A design defect can also occur during the drug’s planning process, and may not be uncovered until the drug has been widely distributed.
Reasons for a Product Recall
While there are many reasons a product recall, the most common include:
- A device needs to be repaired
- The device has a major defect and must be destroyed
- Patients are being monitored for health risks associated with the product
- The settings must be adjusted
- An inspection is required
- New labels or warnings are needed
Companies that manufacture medical devices have an obligation to provide safe and dependable products that work as intended. Even when a medical device works as it should, there are other risks that must be revealed. The law requires product manufacturers to disclose any known issues about the side effects, malfunctions or other potential problems associated with a device.
Common Defective Devices
There are a number of medical devices that may contain defects, such as:
- Dialysis machines
- Defibrillators
- Stents
- Pain pumps
- Spinal discs
- Prosthetics
- Joint replacement parts
- Diagnostic equipment
- Heart valves
Holding the Negligent Party Responsible
In most defective device cases, the manufacturer is responsible for injuries sustained by a faulty device. However, wholesalers, distributors and marketing companies can also be held liable. If one of these parties is responsible for your injuries, you can file a product liability claim.
If you were injured by a device and you believe your doctor, surgeon, nurse or other medical practitioner is responsible, you can file a medical malpractice suit to hold that person liable.
Potential Damages for a Defective Device Suit
If you have been injured because of a defective medical device, you may be eligible for the following compensation:
- Medical expenses (past and future)
- Loss income and future earnings
- Punitive damages (which punish the party responsible)
- Pain and suffering and emotional anguish
Article Source : The Cochran Firm – Product Recalls And Defective Devices : ArticleBase
Erich Shrefler
If you or someone you love has been injured by a defective medical device, please visit the website for The Cochran Firm, serving clients nationwide.
Posted on February 13th, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Thermoflect Recall
Thermoflect blankets and other Thermoflect products have been recalled by Encompass Group for relabeling because they may not be safe for use in the Magnetic Resonance (MR) environment, such as during Magnetic Resonance Imaging (MRI). The Thermoflect recall was prompted by a report to the Food and Drug Administration (FDA) of an injury to an MRI patient. A Thermoflect blanket may or may not have caused the injury.
Thermoflect Products
Thermoflect blankets and other Thermoflect products are used in treating hypothermia. Hypothermia is dangerous lowering of core body temperature. Hypothermia can lead to many serious, acute health issues and complications when it happens in conjunction with other health events.
Thermoflect products help to maintain a patient’s core body temperature both by acting as a regular blanket in preventing heat loss to passing air, and by reflecting the heat coming off of the person’s body back to them. Thermoflect technology is based on NASA pioneered alternatives to electric means of preventing or treating hypothermia.
Thermoflect products do not conduct electricity and do not obstruct X-rays.
The Reason for the Thermoflect Recall
In the past, Encompass Group said that Thermoflect products were safe for use in the MR environment. It says that the product line may indeed be safe in the MR environment, but since an injury linked to the use of a Thermoflect blanket during MRI has been reported, they are going to re-label the products as inappropriate for use in the MR environment and have sent letters to hospitals, doctors, and others warning of the potential danger.
Encompass Group has conducted its own testing of the products, but the American Society for Testing and Materials (ASTM) has not established a standard for testing the products. Encompass Groups says it will not promote Thermoflect products for use in the MR environment until the ASTM establishes a standard and the products are proven safe.
Encompass Groups says that Thermoflect products are still safe and effective for hypothermia treatment outside of the MR environment.
Article Source : Thermoflect Recall – Schlichter, Bogard & Denton : ArticleBase
Erich Shrefler
If you have been injured by a defective medical device or defective drug, please visit the website of Schlichter, Bogard & Denton, experienced defective drug attorneys serving clients nationwide.
Posted on February 13th, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Pharmacy Errors
Every time we as patients are given a medical prescription, we must put our trust in the pharmacy who is filling the prescription and in the healthcare provider who ordered the drug for us. We want to believe they are giving us the right prescription in the right dosage with the right instructions.
Unfortunately, pharmacy mistakes happen every day in the U.S. Some medical watchdog groups estimate that nearly one in every 55 prescriptions contains some type of error.
Some of the mistakes end with no apparent injury. Others can cause catastrophic injury to the patient, including permanent, traumatic brain injury. Some, sadly, even end in wrongful death. Research surveys have shown that more than 7,000 fatalities annually can be contributed to pharmacy errors.
Types of Pharmacy Errors
Pharmacy mistakes can happen at any point in the prescribing, filling and administering process used in the healthcare industry today. A few examples of the errors that can occur include:
- A doctor or other healthcare professional writing a prescription in the wrong dosage amount
- A doctor or other healthcare professional writing a prescription that counteracts with other medicines a patient is taking, with a patient’s known medical conditions or with a known allergy
- A pharmacy incorrectly filling a prescription with a different strength of medicine
- Incorrect labeling placed on a drug package
- Selection by the pharmacist of the wrong drug
- A failure by pharmacy staff to provide instructions on how to take the drug
- Switching prescriptions, giving the wrong drug to the wrong patient
Responsible Parties
Pharmaceutical mistakes are usually associated with pharmacists and pharmacy staff, but other professionals such as doctors, physician assistants, nurses, EMTs and nursing home staff, can be held accountable, as well, in some instances.
Are You At Risk?
National reports show that no one is truly safe from a pharmacy error; patients in both large cities and small rural communities are all at risk.
In fact, several national pharmacy chains, including ones that operate stores in the Washington, D.C. area, have been implicated in pharmacy error investigations, including a four-month study by ABC News’ 20/20 in 2007. (Those national chains included CVS/Pharmacy, Walgreens and Rite Aid, to name a few.)
Nearly 50 percent of fatal pharmacy errors happen to people over the age of 60, but people of all ages, including infants, have died as a result of a medication error, according to the National Coordinating Council for Medication Error Reporting and Prevention.
If you suspect you or someone you love is the victim of a pharmacy error, it is important to speak with an experienced medical malpractice attorney as soon as possible to discuss your case.
Article Source : Pharmacy Errors : ArticleBase
Erich Shrefler
For residents of the D.C. area, please visit the website of the Washington, D.C. medical malpractice lawyers at Chaikin, Sherman, Cammarata & Siegel, P.C.
Posted on February 13th, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
MRI Lawsuit
MRI Lawsuit Funding Now Available To Plaintiffs Diagnosed With Nephrogenic Systemic Fibrosis
TriMark Legal Funding is one of the premier providers of MRI lawsuit loans and Gadolinium lawsuit funding in the United States. We currently offer non-recourse litigation funding (also called settlement funding, lawsuit loans or lawsuit cash advances) to plaintiffs who acquired Nephrogenic Systemic Fibrosis (NSF) from being injected with Gadolinium-based MRI contrast dye and who have a pending MRI dye lawsuit or Gadolinium lawsuit.
There are five different Gadolinium MRI contrasting agents that were approved for use in the United States and that have been linked to Nephrogenic Systemic Fibrosis. They are Omniscan® (Gadodiamide) manufactured by GE Healthcare,OptiMARK® (Gadoversetamide) manufactured by Mallinckrodt and Tyco Healthcare, Magnevist® (Gadopentetate Dimeglumine) made by Bayer HealthCare, Berlex and Schering AG; ProHance® (Gadoteridol) and MultiHance®(Gadobenate Dimeglumine) both made by Bracco Diagnostics.
Lawsuit Funding is 100% Risk-Free to Plaintiffs
It doesn’t cost anything to apply; there are no up-front or out-of-pocket costs; income, employment history and bad credit are don’t matter; we do not interfere with your attorney’s handling of your case and we do not try to take over case management, there are no monthly payments, and perhaps best of all, repayment of the advance is contingent upon the successful outcome of your litigation. In other words, if you lose your MRI lawsuit or it does not settle, you are under no obligation to repay the money we advanced you. This can help put your mind at ease, knowing that in the unlikely event that you do not prevail, you will not owe yet another debt.
Lawsuit funding is FAST. In fact, if you qualify and with your attorney’s cooperation, you could receive your money the very next business day. Your attorney can submit the required paperwork, and you don’t have to worry about your credit ratings, previous employment or even a discharged bankruptcy – none of this has a bearing on your eligibility.
Personal injury litigation can take a long time and many plaintiffs, particularly those who have developed NSF, are frequently unable to work and often find they are running short on money. MRI lawsuit settlement funding is a fast, easy, no-risk way for plaintiffs with MRI lawsuits to gain immediate access to a portion of their future Gadolinium settlement money right now.
This money can then be used at the plaintiff’s discretion for debt elimination, monthly bills, household expenses and other necessities. This is important because, while it’s true that many Gadolinium settlements have been in the high 6 and 7 figure range, Nephrogenic Systemic Fibrosis is a debilitating and often fatal disease that progresses quickly and worsens over time, so time is of the essence. If you’re like most plaintiffs, you don’t mind waiting for the bulk of your settlement, but perhaps you just need some immediate financial assistance in order to hold out for the maximum settlement possible.
Also, many plaintiffs who are involved in MRI lawsuits opt for a lawsuit cash advance in order to pay for things they wish to accomplish BEFORE their disease progresses to the point where achieving them is no longer an option. In other words, they view taking an advance on their future settlement money as a way to maximize their quality of life now, when it matters most. It is also important for the peace of mind of many plaintiffs afflicted with NSF to be able to “tie up loose ends” and “put their financial house in order” while they still have time and the physical capacity to do so.
Qualifying for non-recourse MRI lawsuit funding is fast, free and easy. Because it’s not a loan, there is no long, intrusive application process like there is with a bank loan. There are also no monthly payments to contend with, no income or employment requirements and damaged or bad credit is completely irrelevant. That’s because we approve and fund Gadolinium lawsuit advances based entirely on the strength and merit of the individual case – NOT on a plaintiff’s creditworthiness or ability to make monthly payments.
MRI lawsuit funding is flexible. It’s YOUR money, so you are free to request as much or as little as you need and to use the money for any purpose you choose such as paying off bills, catching up on rent or your mortgage, medical equipment or expenses, home and vehicle modifications, emergency travel, etc.
The approval process is fast, free and easy:
- Plaintiffs can begin by completing and returning our online application. It only takes about 3 or 4 minutes to complete, is kept strictly confidential and is available 24 hours a day, 7 days a week. You may also download a printable version if you prefer. If you have trouble opening the application or prefer an application be emailed or faxed to you, please call us toll-free at 1.877.932.2628.
- After we receive your application, we will immediately fax a document request to your attorney to obtain some case-related information to evaluate your case. For Gadolinium lawsuits, we simply need a copy of the complaint, proof of drug usage (pharmacy prescription records), proof of NSF / NFD diagnosis and a copy of the settlement letter (if available).
- After we receive the requested information from your attorney, our underwriting evaluation normally takes about 1 business day. Our maximum approval amount is typically up to between 10% and 15% of an anticipated settlement, however we encourage plaintiffs to request only the amount of money they feel they will actually need to achieve their financial goals over the next 3 to 6 months. You can always request more money in 3 to 6 months if needed, and this will also go a long way toward helping to keep the cost of the lawsuit advance as low as possible.
- After approval, a funding agreement is emailed or faxed out; you and your attorney sign and return it.
- Your money is either wired directly into your bank account or a check is sent to you FedEx overnight.
Please call us toll-free at 1.877.932.2628 and we will be happy to discuss your case and answer any questions you may have.
TriMark Legal Funding is a leading provider of lawsuit loans and pre settlement funding, post settlement funding and appeal funding for plaintiffs and we also offer attorney funding and law firm financing in all 50 states including Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin and Wyoming. AL, AK, AZ, AR, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NV, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV & WY.
Posted on February 3rd, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Nephrogenic Systemic Fibrosis

Nephrogenic Systemic Fibrosis: MRI Lawsuit Funding / Gadolinium Lawsuit Loans (Non-Recourse) Are Now Available To Plaintiffs With Nephrogenic Systemic Fibrosis
TriMark Legal Funding is one of the premier providers of MRI lawsuit loans and Gadolinium lawsuit funding in the United States. We are currently offering no-risk, non-recourse settlement funding (also called litigation funding, a lawsuit loan or lawsuit cash advance) to plaintiffs who acquired Nephrogenic Systemic Fibrosis (NSF) (formerly known as Nephrogenic Fibrosing Dermopathy or NFD) from exposure to Gadolinium-based MRI contrast dye and have pending MRI dye lawsuits or Gadolinium litigation.
There are five different Gadolinium MRI contrasting agents approved for use in the United States that have been linked to Nephrogenic Systemic Fibrosis. They are Omniscan® (Gadodiamide) manufactured by GE Healthcare, OptiMARK® (Gadoversetamide) manufactured by Mallinckrodt and Tyco Healthcare, Magnevist® (Gadopentetate Dimeglumine) made by Bayer HealthCare, Berlex and Schering AG; ProHance® (Gadoteridol) and MultiHance® (Gadobenate Dimeglumine) both made by Bracco Diagnostics.
Non-Recourse Settlement Funding is 100% Risk-Free to Plaintiffs
It’s free to apply; there are no up-front or out-of-pocket costs; income, employment history and bad credit are all irrelevant; we do not interfere with your attorney’s handling of your case and we do not try to take over case management, there are no monthly payments, and perhaps best of all, repayment of the advance is contingent upon the successful outcome of your litigation. In other words, if you lose your MRI lawsuit or it does not settle, you are under no obligation to repay the money we advanced you. This can help put your mind at ease, knowing that in the unlikely event that you do not prevail, you will not owe yet another debt.
Lawsuit funding is FAST. In fact, if you qualify and with your attorney’s cooperation, you could receive your money the very next business day. Your attorney can submit the required paperwork, and you don’t have to worry about your credit ratings, previous employment or even a discharged bankruptcy – none of this has a bearing on your eligibility.
Personal injury litigation can take a long time and many plaintiffs, particularly those who have developed NSF, are frequently unable to work and often find they are running short on money. MRI lawsuit settlement funding is a fast, easy, no-risk way for plaintiffs with MRI lawsuits to gain immediate access to a portion of their future Gadolinium settlement money right now.
This money can then be used at the plaintiff’s discretion for debt elimination, monthly bills, household expenses and other necessities. This is important because, while it’s true that many Gadolinium settlements have been in the high 6 and 7 figure range, Nephrogenic Systemic Fibrosis is a debilitating and often fatal disease that progresses quickly and worsens over time, so time is of the essence. If you’re like most plaintiffs, you don’t mind waiting for the bulk of your settlement, but perhaps you just need some immediate financial assistance in order to hold out for the maximum settlement possible.
Also, many plaintiffs who are involved in MRI lawsuits opt for a lawsuit cash advance in order to pay for things they wish to accomplish BEFORE their disease progresses to the point where achieving them is no longer an option. In other words, they view taking an advance on their future settlement money as a way to maximize their quality of life now, when it matters most. It is also important for the peace of mind of many plaintiffs afflicted with NSF to be able to “tie up loose ends” and “put their financial house in order” while they still have time and the physical capacity to do so.
Qualifying for non-recourse MRI lawsuit funding is fast, free and easy. Because it’s not a loan, there is no long, intrusive application process like there is with a bank loan. There are also no monthly payments to contend with, no income or employment requirements and damaged or bad credit is completely irrelevant. That’s because we approve and fund Gadolinium lawsuit advances based entirely on the strength and merit of the individual case – NOT on a plaintiff’s creditworthiness or ability to make monthly payments.
MRI lawsuit funding is flexible. It’s YOUR money, so you are free to request as much or as little as you need and to use the money for any purpose you choose such as paying off bills, catching up on rent or your mortgage, medical equipment or expenses, home and vehicle modifications, emergency travel, etc.
The approval process is fast, free and easy:
- Plaintiffs can begin by completing and returning our online application. It only takes about 3 or 4 minutes to complete, is kept strictly confidential and is available 24 hours a day, 7 days a week. You may also download a printable version if you prefer. If you have trouble opening the application or prefer an application be emailed or faxed to you, please call us toll-free at 1.877.932.2628.
- After we receive your application, we will immediately fax a document request to your attorney to obtain some case-related information to evaluate your case. For Gadolinium lawsuits, we simply need a copy of the complaint, proof of drug usage (pharmacy prescription records), proof of NSF / NFD diagnosis and a copy of the settlement letter (if available).
- After we receive the requested information from your attorney, our underwriting evaluation normally takes about 1 business day. Our maximum approval amount is typically up to between 10% and 15% of an anticipated settlement, however we encourage plaintiffs to request only the amount of money they feel they will actually need to achieve their financial goals over the next 3 to 6 months. You can always request more money in 3 to 6 months if needed, and this will also go a long way toward helping to keep the cost of the lawsuit advance as low as possible.
- After approval, a funding agreement is emailed or faxed out; you and your attorney sign and return it.
- Your money is either wired directly into your bank account or a check is sent to you FedEx overnight.
Please call us toll-free at 1.877.932.2628 and we will be happy to discuss your case and answer any questions you may have.
TriMark Legal Funding is a leading provider of lawsuit loans and pre settlement funding, post settlement funding and appeal funding for plaintiffs and we also offer attorney funding and law firm financing in all 50 states including Alabama, Alaska, Arizona, Arkansas, California, Colorado, Connecticut, Delaware, District of Columbia, Florida, Georgia, Hawaii, Idaho, Illinois, Indiana, Iowa, Kansas, Kentucky, Louisiana, Maine, Maryland, Massachusetts, Michigan, Minnesota, Mississippi, Missouri, Montana, Nebraska, Nevada, New Hampshire, New Jersey, New Mexico, New York, North Carolina, North Dakota, Ohio, Oklahoma, Oregon, Pennsylvania, Rhode Island, South Carolina, South Dakota, Tennessee, Texas, Utah, Vermont, Virginia, Washington, Washington DC, West Virginia, Wisconsin and Wyoming. AL, AK, AZ, AR, CA, CO, CT, DC, DE, FL, GA, HI, ID, IL, IN, IA, KS, KY, LA, ME, MD, MA, MI, MN, MS, MO, MT, NC, ND, NE, NV, NH, NJ, NM, NY, OH, OK, OR, PA, RI, SC, SD, TN, TX, UT, VT, VA, WA, WV & WY.
Posted on February 3rd, 2010 | By: admin | Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Now Funding Avandia, Bextra, Gadolinium, Reglan and More!
Need Cash From Your Pharmaceutical Settlement?
TriMark Legal Funding has great news about a number of pharmaceutical MDL’s (multi-district litigation or class action lawsuits).
Wyeth v. Levine was decided on March 4, 2009 by the US Supreme Court. The result of that decision is that the issue of “pre-emption” is now considered a moot point. Simply put, the Supreme Court has decided that just because drugs provide a warning label, injured parties can still pursue “failure to warn” claims.
TriMark Legal Funding is now moving aggressively forward to provide pre settlement funding on the following MDL’s:
- Accutane
- Avandia Lawsuit
- Bextra
- Celebrex
- Duragesic Patch
- Gadolinium MRI
- Kugel Mesh
- Prempro
- Reglan Lawsuit
We have done our research already and the time has arrived. This is a MAJOR development and TriMark Legal Funding is one of the only settlement funding companies in the US to provide litigation financing or pre settlement funding on Accutane, Avandia, Bextra, Celebrex, Duragesic Patch, Gadolinium, Kugel Mesh and Prempro class action lawsuits.
Visit TriMark Legal Funding for more information or to apply for a lawsuit cash advance now!
Posted on April 10th, 2009 | By: admin | Tags: accutane, avandia, bextra, celebrex, class action lawsuit, Duragesic Patch, gadolinium, kugel mesh, lawsuit funding, litigation financing, mdl, pre settlement funding, prempro
Filed under Pharmaceutical Lawsuits, Plaintiff Lawsuit Funding
Is ANYONE Still Funding Vioxx Settlements?
Is ANYONE Still Funding Vioxx Settlements?
The short answer is “YES … TriMark Legal Funding is STILL funding Vioxx settlements and cash advances, but you need to hurry.” The reality is that we are just about the only lawsuit funding company left in the United States that is still funding cash advances on the Vioxx/Merck settlement.
If you’re like most of the qualified members of the Merck Vioxx settlement, you’re looking for Vioxx settlement news or a Vioxx settlement update because the question on everyone’s mind seems to be ‘what’s going on with mysettlement money’, right?
The Vioxx MDL
Everyone knows the Vioxx MDL is one of the largest multi-district ligitation cases in US legal history, but despite that, news on Vioxx settlement payments has been slow. First they agreed to the settlement in 2007, then they said you’d get your money maybe starting in February 2008, then August, then November. Then they stalled and said more people were being added to the settlement class and gave them until the end of October to join and now it’s up in the air again. So if you’re like most folks in the Vioxx settlement, you’re probably wondering what is going on with your money … and more specifically, WHEN EXACTLY you’re going to receive your settlement check.
Vioxx lawsut settlement funding (also called lawsuit funding, lawsuit loans, a settlement cash advance or Vioxx settlement funding) was offered by a lot of companies during the first part of 2008, but as there have been more and more delays, more and more companies have decided to stop funding cash advances for Vioxx. In fact, just about every litigation financing firm has stopped funding against settlement proceeds from Vioxx.
Every firm EXCEPT TriMark Legal Funding that is.
24 Hour Approval
TriMark Legal Funding is still offering and still funding Vioxx lawsuit loans and cash advances. And our process is streamlined so you can get your money FAST. In fact, once we’ve received your application and some basic information from your attorney, we can usually have your request approved within 12-24 hours (1 business day or less)!
Our Vioxx settlement funding is not only fast and 100% risk-free, so we get you the money you need WHEN you need it, but it’s also super-easy to apply and easy to get approved too.
We can typically advance up to about 15% of your anticipated settlement (of course, you don’t HAVE to take that much – we can fund any amount from $1,000 up to a MAXIMUM of about 15%). Plus there are no application fees, no up-front fees and no out-of-pocket costs to worry about either.
The most important thing to remember is that while practically everyone else has stopped funding Vioxx cash advances, TriMark Legal Funding is STILL FUNDING Vioxx settlements daily! Apply now and you could get the money you need in a day or two and then just pay us back when your Vioxx settlement arrives – whenever that happens to be.
You can learn more about our Vioxx Settlement Funding, calculate how much you’re due with a Vioxx settlement calculator, apply online or call us toll-free at 1-877-932-2628 and we’ll be happy to discuss your case and answer any questions you have.
Posted on December 31st, 2008 | By: admin | Filed under Pharmaceutical Lawsuits
Gadolinium Lawsuit Funding Now Available
Gadolinium Litigation Financing
TriMark Legal Funding is proud to announce that is it one of the only litigation financing companies in the United States that is now offering Gadolinium lawsuit settlement funding on cases involving Gadolinium based MRI contrasting solutions.
On May 23, 2007 the FDA issued a public health advisory and cited recent findings that clearly indicated Gadolinium side effects from using Gadolinium based MRI contrasting agents significantly increased the risk of developing Nephrogenic Systemic Fibrosis/Nephrogenic Fibrosing Dermopathy (NSF/NFD).
The FDA is currently evaluating important safety information about Gadolinium-containing contrasting agents and NSF/NFD that occurs in patients with kidney failure. New reports have identified a possible link between NSF/NFD and exposure to Gadolinium-containing contrast agents used at high doses for a procedure called Magnetic Resonance Angiography, MRA. The dose of Gadolinium- containing contrast agents given to patients undergoing an MRA are often higher (up to three times higher) than the approved dose for an MRI.
Gadolinium or Gadodiamide
The FDA approved Gadolinium for use in MRI in 1988. Gadolinium solution is clear like water, after injection into a vein Gadolinium accumulates in the abnormal tissue that may be affecting the body or head. Gadolinium then causes these areas to appear very bright on the MRI, making them easy to see. Gadolinium is then rapidly cleared from the body by the kidneys.
Less than one in one thousand patients is allergic to Gadolinium. If a patient has kidney problems, Gadolinium based contrasting agents should be used with extreme caution.
What Is Nephrogenic Systemic Fibrosis?
Nephrogenic Systemic Fibrosis (NSF/NFD) is a progressive, debilitating disease that affects people with pre-existing kidney disease.
NSF/NFD is characterized by high blood pressure, burning, itching, swelling and hardening of the skin. Other symptoms include red or dark patches on the skin, pain deep in the hip bones or ribs and muscle weakness. NSF/NFD causes the development of excessive scar tissue and thick, tight, hardened areas of skin which often cover the joints, resulting in severe limitations on movement. It frequently renders the victim unable to walk or fully move the joints of their arms, hands, legs and/or feet and many become dependent on a wheelchair within weeks of the onset. In some cases it can even lead to death.
It can take some time after exposure to Gadolinium for symptoms to appear and the disease often progresses very slowly. At this time there is no known treatment or cure for NSF/NFD.
The first case of NSF/NFD was reported in 1997 and first appeared in medical literature in 2000. Gadolinium based contrast agents currently in use:
- Magnevist (gadopentetate dimeglumine) manufactured by Bayer Health Care
- MultiHance (gabobenate dimeglumine) manufactured by Bracco
- Omniscan (gadodiamide) manufactured by G.E. Healthcare
- OptiMARK (gadoversetamide) manufactured by Mallinckrodt
- ProHance (gadoteridol) manufactured by Bracco
On April 17th 2009 the FDA issued a Black Box warning (the FDA’s most serious type of warning) for healthcare providers concerning their prescription information for Gadolinium–based contrast agents used during MRI. A Black Box warning has now also been added to the product’s label.
Gadolinium Lawsuit Settlement Funding
Gadolinium lawsuits are also sometimes referred to as “MRI Lawsuits” or “MRI Dye Lawsuits”. To apply for a Gadolinium lawsuit settlement cash advance on your Gadolinium case, all you need to do to get started is complete our short application – it’s free to apply and you can even do it online if you’d like. After we receive your application, we’ll get the rest of the paperwork we need directly from your attorney, and once we’ve received it, we can usually have an approval within 2-3 business days. We can wire your money directly into your bank account the same day or FedEx you a check overnight! Best of all, there are no application fees, up-front fees or out-of-pocket costs and it’s free to apply.
If you need financial help right now, you can learn more about the specifics of Gadolinium lawsuit funding or apply right now.
You can learn more by visiting our Litigation Financing website or you can call TriMark Legal Funding directly at 1.877.932.2628 and we’ll be happy to discuss your particular case and answer any questions you might have.
Posted on December 23rd, 2008 | By: admin | Tags: gadolinium, gadolinium lawsuit settlements, gadolinium side effects, mri dye lawsuits, mri lawsuits, nephrogenic fibrosing dermopathy, nephrogenic systemic fibrosis, nephrogenic systemic fibrosis treatment, side effects of gadolinium
Filed under Pharmaceutical Lawsuits

















